PT  - JOURNAL ARTICLE
AU  - Daneshkhah, Ali
AU  - Agrawal, Vasundhara
AU  - Eshein, Adam
AU  - Subramanian, Hariharan
AU  - Roy, Hemant K.
AU  - Backman, Vadim
TI  - The Possible Role of Vitamin D in Suppressing Cytokine Storm and Associated Mortality in COVID-19 Patients
AID  - 10.1101/2020.04.08.20058578
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.04.08.20058578
4099  - http://medrxiv.org/content/early/2020/05/18/2020.04.08.20058578.short
4100  - http://medrxiv.org/content/early/2020/05/18/2020.04.08.20058578.full
AB  - Objectives To investigate the possible role of Vitamin D (Vit D) deficiency via unregulated inflammation in COVID-19 complications and associated mortality.Design The time-adjusted case mortality ratio (T-CMR) was estimated as the number of deceased patients on day N divided by the number of confirmed cases on day N-8. The adaptive average of T-CMR (A-CMR) was further calculated as a metric of COVID-19 associated mortality in different countries. A model based on positivity change (PC) and an estimated prevalence of COVID-19 was developed to determine countries with similar screening strategies. Mean concentration of 25-hydroxyvitamin D (25(OH)D) in elderly individuals in countries with similar screening strategies were compared to investigate the potential impact of Vit D on A-CMR. We analyzed data showing a possible association between high C-Reactive Protein (CRP) concentration (CRP ≥ 1 mg/dL) and severe COVID-19. We estimated a link between Vit D status and high CRP in healthy subjects (CRP ≥ 0.2 mg/dL) with an adjustment for age and income to explore the possible role of Vit D in reducing complications attributed to unregulated inflammation and cytokine production.Data Sources Daily admission, recovery and deceased rate data for patients with COVID-19 were collected from Kaggle as of April 20, 2020. Screening data were collected from Our World in Data and official statements from public authorities. The mean concentration of 25(OH)D among the elderly for comparison with A-CMR was collected from previously published studies from different countries. Chronic factor data used in regression analysis was obtained from published articles. The correlation between Vit D and CRP was calculated based on 9,212 subject-level data from NHANES, 2009-2010.Results A link between 25(OH)D and A-CMR in the US, France, Iran and the UK (countries with similar screening status) may exist. We observed an inverse correlation (correlation coefficient ranging from −0.84 to −1) between high CRP and 25(OH)D. Age and the family income status also correlated to high CRP and subjects with higher age and lower family income presented more incidences of high CRP. Our analysis determined a possible link between high CRP and Vit D deficiency and calculated an OR of 1.8 with 95%CI (1.2 to 2.6) among the elderly (age ≥ 60 yo) in low-income families and an OR of 1.9 with 95%CI (1.4 to 2.7) among the elderly (age ≥ 60 yo) in high-income families. COVID-19 patient-level data shows a notable OR of 3.4 with 95%CI (2.15 to 5.4) for high CRP in severe COVID-19 patients.Conclusion Given that CRP is a surrogate marker for cytokine storm and is associated with Vit D deficiency, based on retrospective data and indirect evidence we see a possible role of Vit D in reducing complications attributed to unregulated inflammation and cytokine storm. Further research is needed to account for other factors through direct measurement of Vit D levels in COVID-19 patients.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe authors would like to thank Benjamin D Keane for his assistance in preparing the manuscript. The authors would also like to acknowledge generous support from the Carinato Charitable Foundation, Mark and Ingeborg Holliday, Kristin Hudson & Rob Goldman, and Ms. Susan Brice & Mr. Jordi Esteve.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData regarding the number of affected cases, deaths, and recoveries from COVID-19 was obtained from Kaggle[24] as of April 20, 2020. Data regarding cases that have undergone testing were obtained from Our World in Data[25]. Age distribution of confirmed cases, those admitted to ICU, and deceased patients in Spain was based on data available from the Spanish Ministry of Health[26]. The concentration of 25(OH)D among the elderly population in each country was obtained from prior studies[27-32]. CRP data, Vit D, data and demographic variables of the subjects were pooled the cross-sectional data from 2009-2010 NHANES, conducted by the National Center for Health Statistics (NCHS), Centers for Disease Control and Prevention (CDC) [22]. Data regarding the risk factors including blood pressure[33], body to mass ratio[34], and diabetes[35], were obtained from published articles. Data on coronary heart disease (CHD) death rates across different countries was used based on the calculation of World Life Expectancy on data reported by the World Health Organization (WHO) [36]. The link between high CRP and severe COVID-19 was examined based on data from a study investigating the characteristics of COVID-19 patients in China[23]. References: 22 NHANES 2009-2010 Laboratory Data. https://wwwn.cdc.gov/nchs/nhanes/search/datapage.aspx?Component=Laboratory&CycleBeginYear=2009 (accessed 13 May 2020). 23 Guan W, Ni Z, Hu Y, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med 2020;0:null. doi:10.1056/NEJMoa2002032 24 Novel Corona Virus 2019 Dataset. https://kaggle.com/sudalairajkumar/novel-corona-virus-2019-dataset (accessed 1 Apr 2020). 25 To understand the global pandemic, we need global testing - the Our World in Data COVID-19 Testing dataset. Our World Data. https://ourworldindata.org/covid-testing (accessed 13 Apr 2020). 26 Informes COVID-19. https://www.isciii.es/QueHacemos/Servicios/VigilanciaSaludPublicaRENAVE/EnfermedadesTransmisibles/Paginas/InformesCOVID-19.aspx (accessed 4 Apr 2020). 27 Basile M, Ciardi L, Crespi I, et al. Assessing serum concentrations of 25-hydroxy-vitamin d in north-western Italy. J Frailty Aging 2013;2:174-8. doi:10.14283/jfa.2013.25 28 Toffanello ED, Perissinotto E, Sergi G, et al. Vitamin D and Physical Performance in Elderly Subjects: The Pro.V.A Study. PLOS ONE 2012;7:e34950. doi:10.1371/journal.pone.0034950 29 Adami S, Viapiana O, Gatti D, et al. Relationship between serum parathyroid hormone, vitamin D sufficiency, age, and calcium intake. Bone 2008;42:267-70. doi:10.1016/j.bone.2007.10.003 30 González-Molero I, Morcillo S, Valdés S, et al. Vitamin D deficiency in Spain: a population-based cohort study. Eur J Clin Nutr 2011;65:321-8. doi:10.1038/ejcn.2010.265 31 Rabenberg M, Scheidt-Nave C, Busch MA, et al. Vitamin D status among adults in Germany - results from the German Health Interview and Examination Survey for Adults (DEGS1). BMC Public Health 2015;15. doi:10.1186/s12889-015-2016-7 32 Park J-H, Hong IY, Chung JW, et al. Vitamin D status in South Korean population. Medicine (Baltimore) 2018;97. doi:10.1097/MD.0000000000011032 33 Zhou B, Bentham J, Cesare MD, et al. Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19·1 million participants. The Lancet 2017;389:37-55. doi:10.1016/S0140-6736(16)31919-5 34 Abarca-Gómez L, Abdeen ZA, Hamid ZA, et al. Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults. The Lancet 2017;390:2627-42. doi:10.1016/S0140-6736(17)32129-3 35 Zhou B, Lu Y, Hajifathalian K, et al. Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4·4 million participants. The Lancet 2016;387:1513-30. doi:10.1016/S0140-6736(16)00618-8 36 Coronary heart disease death rate by country. World Life Expect. https://www.worldlifeexpectancy.com/cause-of-death/coronary-heart-disease/by-country/ (accessed 13 May 2020). https://www.kaggle.com/sudalairajkumar/novel-corona-virus-2019-dataset https://population.un.org/wpp/Download/Standard/Population/ https://www.who.int/vmnis/en/ https://www.isciii.es/QueHacemos/Servicios/VigilanciaSaludPublicaRENAVE/EnfermedadesTransmisibles/Paginas/InformesCOVID-19.aspx http://ncdrisc.org/data-downloads.html https://www.santepubliquefrance.fr/maladies-et-traumatismes/maladies-et-infections-respiratoires/infection-a-coronavirus/documents/bulletin-national/covid-19-point-epidemiologique-du-15-mars-2020 https://www.epicentro.iss.it/en/coronavirus/ https://wwwn.cdc.gov/nchs/nhanes/Search/DataPage.aspx?Component=Laboratory&CycleBeginYear=2009 https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/551352/NDNS_Y5_6_UK_Main_Text.pdf https://ourworldindata.org/covid-testing